Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Depreciation & Amortization (CF) (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 426.73% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 51.27% year-over-year, with the annual reading at $4.5 million for FY2025, 51.27% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $2.9 million at Pyxis Oncology, up from $527000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $2.9 million in Q4 2025, with the low at $527000.0 in Q3 2025.